MétaCan
Menu
Back to cohort
Record W4282826652 · doi:10.1126/sciimmunol.abp8966

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs

2022· article· en· W4282826652 on OpenAlexaff
Paul Bastard, Sara E. Vazquez, Jamin Liu, Matthew T. Laurie, Chung‐Yu Wang, Adrian Gervais, Lucy Bizien, Colin R. Zamecnik, Quentin Philippot, Jérémie Rosain, Émilie Catherinot, Andrew Willmore, Anthea Mitchell, Rebecca Bair, Pierre Garçon, Heather Kenney, Arnaud Fekkar, Maria Salagianni, Garyphallia Poulakou, Eleni Siouti, Sabina Sahanic, Ivan Tancevski, Günter Weiß, Laurenz Nagl, Jérémy Manry, Sotiriјa Duvlis, Daniel Arroyo‐Sánchez, Estela Paz‐Artal, Luis Rubio, Cristiano Perani, Michela Bezzi, Alessandra Sottini, Virginia Quaresima, Lucie Roussel, Donald C. Vinh, Luis Felipe Reyes, Margaux Garzaro, Nevin Hatipoğlu, David Boutboul, Yacine Tandjaoui-Lambiotte, A. Borghesi, Anna Aliberti, Irene Cassaniti, Fabienne Venet, Guillaume Monneret, Rabih Halwani, Narjes Saheb Sharif‐Askari, Jeffrey J. Danielson, Sonia Burrel, Caroline Morbieu, Yuriy Stepanovskyy, Анастасія Бондаренко, Алла Волоха, Oksana Boyarchuk, Alenka Gagro, Mathilde Neuville, Bénédicte Neven, Sevgi Keleş, Romain Hernu, Antonin Bal, Antonio Novelli, Giuseppe Novelli, Kahina Saker, Oana Ailioaie, Arnau Antolí, Éric Jeziorski, Gemma Rocamora-Blanch, Carla Teixeira, Clarisse Delaunay, Marine Lhuillier, Paul Le Turnier, Yu Zhang, Matthieu Mahévas, Qiang Pan‐Hammarström, Hassan Abolhassani, Thierry Bompoil, Karim Dorgham, Guy Gorochov, Cédric Laouenan, Carlos Rodríguez‐Gallego, Lisa F. P. Ng, Laurent Rénia, Aurora Pujol, Alexandre Bélot, F. Raffi, Luís M. Allende, Javier Martínez‐Picado, Tayfun Özçelık, Luisa Imberti, Luigi D. Notarangelo, Jesús Troya, Xavier Solanich, Shen‐Ying Zhang, Anne Puel, Michael R. Wilson, Sophie Trouillet‐Assant, Laurent Abel, Emmanuelle Jouanguy, Chun Ye, Aurélie Cobat, Leslie M. Thompson, Evangelos Andreakos, Qian Zhang, Mark S. Anderson, Jean‐Laurent Casanova, Joseph L. DeRisi

Bibliographic record

VenueScience Immunology · 2022
Typearticle
Languageen
FieldMedicine
TopicSARS-CoV-2 and COVID-19 Research
Canadian institutionsHotel Dieu HospitalMcGill University Health Centre
FundersChao Family Comprehensive Cancer CenterInstituto de Salud Carlos IIINational Center for Research ResourcesFisher Center for Alzheimer's Research FoundationAgence Nationale de la RechercheNational Institute of Allergy and Infectious DiseasesNational Center for Advancing Translational SciencesMedical Research CouncilMercatus Center, George Mason UniversityUniversity of California, San FranciscoNovo Nordisk FondenEuropean CommissionMinisterio de Ciencia e InnovaciónFundación MapfreFondation pour la Recherche MédicaleFondation du SouffleInstitut National de la Santé et de la Recherche MédicaleHellenic Foundation for Research and InnovationGeorgia Clinical and Translational Science AllianceNational Cancer InstituteNational Medical Research CouncilMinistère de l'Enseignement supérieur, de la Recherche et de l'InnovationAgencia Estatal de InvestigaciónSt. Giles FoundationGeorge Mason UniversityNational Institutes of Health
KeywordsCoronavirus disease 2019 (COVID-19)PneumoniaVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMedicineImmunologyBiologyOutbreakInternal medicineDiseaseInfectious disease (medical specialty)

Abstract

fetched live from OpenAlex

Life-threatening "breakthrough" cases of critical COVID-19 are attributed to poor or waning antibody (Ab) response to SARS-CoV-2 vaccines in individuals already at risk. Preexisting auto-Abs neutralizing type I IFNs underlie at least 15% of critical COVID-19 pneumonia cases in unvaccinated individuals; their contribution to hypoxemic breakthrough cases in vaccinated people is unknown. We studied a cohort of 48 individuals (aged 20 to 86 years) who received two doses of a messenger RNA (mRNA) vaccine and developed a breakthrough infection with hypoxemic COVID-19 pneumonia 2 weeks to 4 months later. Ab levels to the vaccine, neutralization of the virus, and auto-Abs to type I IFNs were measured in the plasma. Forty-two individuals had no known deficiency of B cell immunity and a normal Ab response to the vaccine. Among them, 10 (24%) had auto-Abs neutralizing type I IFNs (aged 43 to 86 years). Eight of these 10 patients had auto-Abs neutralizing both IFN-α2 and IFN-ω, whereas two neutralized IFN-ω only. No patient neutralized IFN-β. Seven neutralized type I IFNs at 10 ng/ml and three at 100 pg/ml only. Seven patients neutralized SARS-CoV-2 D614G and Delta efficiently, whereas one patient neutralized Delta slightly less efficiently. Two of the three patients neutralizing only type I IFNs at 100 pg/ml neutralized both D614G and Delta less efficiently. Despite two mRNA vaccine inoculations and the presence of circulating Abs capable of neutralizing SARS-CoV-2, auto-Abs neutralizing type I IFNs may underlie a notable proportion of hypoxemic COVID-19 pneumonia cases, highlighting the importance of this particularly vulnerable population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.335
Teacher spread0.308 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations77
Published2022
Admission routes1
Has abstractyes

Explore more

Same venueScience ImmunologySame topicSARS-CoV-2 and COVID-19 ResearchFrench-language works237,207